DK3459542T3 - Anvendelse af carbamatforbindelse til forebyggelse eller behandling af trigeminusneuralgi - Google Patents

Anvendelse af carbamatforbindelse til forebyggelse eller behandling af trigeminusneuralgi Download PDF

Info

Publication number
DK3459542T3
DK3459542T3 DK17799674.1T DK17799674T DK3459542T3 DK 3459542 T3 DK3459542 T3 DK 3459542T3 DK 17799674 T DK17799674 T DK 17799674T DK 3459542 T3 DK3459542 T3 DK 3459542T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
carbamate compound
trigeminus neuralgia
trigeminus
Prior art date
Application number
DK17799674.1T
Other languages
Danish (da)
English (en)
Inventor
Min Jae Jo
Sun Gwan Hwang
Han Ju Yi
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of DK3459542T3 publication Critical patent/DK3459542T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17799674.1T 2016-05-19 2017-05-18 Anvendelse af carbamatforbindelse til forebyggelse eller behandling af trigeminusneuralgi DK3459542T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061386 2016-05-19
PCT/KR2017/005172 WO2017200317A1 (ko) 2016-05-19 2017-05-18 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
DK3459542T3 true DK3459542T3 (da) 2021-09-13

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17799674.1T DK3459542T3 (da) 2016-05-19 2017-05-18 Anvendelse af carbamatforbindelse til forebyggelse eller behandling af trigeminusneuralgi

Country Status (14)

Country Link
US (1) US11207295B2 (https=)
EP (1) EP3459542B1 (https=)
JP (1) JP6960415B2 (https=)
KR (1) KR102421013B1 (https=)
CN (1) CN109310669B (https=)
AU (1) AU2017267160B2 (https=)
CA (1) CA3024284C (https=)
DK (1) DK3459542T3 (https=)
ES (1) ES2887338T3 (https=)
MX (1) MX389613B (https=)
PL (1) PL3459542T3 (https=)
PT (1) PT3459542T (https=)
RU (1) RU2751504C2 (https=)
WO (1) WO2017200317A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556365B1 (en) * 2016-12-14 2025-07-02 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
ES2978226T3 (es) * 2018-09-21 2024-09-09 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
AU2019361856B2 (en) * 2018-10-19 2024-11-07 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
IL157593A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
WO2010150946A1 (en) 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CA2817290A1 (en) * 2010-11-11 2012-05-18 Josef Penninger Compounds and methods for treating pain
MX368735B (es) 2014-05-09 2019-10-14 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.

Also Published As

Publication number Publication date
WO2017200317A1 (ko) 2017-11-23
RU2751504C2 (ru) 2021-07-14
CN109310669B (zh) 2022-02-22
KR102421013B1 (ko) 2022-07-14
EP3459542A4 (en) 2020-01-08
KR20170131241A (ko) 2017-11-29
US11207295B2 (en) 2021-12-28
JP6960415B2 (ja) 2021-11-05
PL3459542T3 (pl) 2021-12-27
AU2017267160A1 (en) 2018-12-13
AU2017267160B2 (en) 2022-11-10
RU2018144784A (ru) 2020-06-19
PT3459542T (pt) 2021-08-24
MX2018014081A (es) 2019-09-02
US20190175555A1 (en) 2019-06-13
CA3024284A1 (en) 2017-11-23
US20220087976A1 (en) 2022-03-24
EP3459542B1 (en) 2021-06-30
RU2018144784A3 (https=) 2020-08-11
ES2887338T3 (es) 2021-12-22
CA3024284C (en) 2024-01-23
JP2019516722A (ja) 2019-06-20
MX389613B (es) 2025-03-20
EP3459542A1 (en) 2019-03-27
BR112018073556A2 (pt) 2019-03-19
CN109310669A (zh) 2019-02-05

Similar Documents

Publication Publication Date Title
DK3501542T3 (da) Esketamin til behandling af depression
DK3285803T3 (da) Fremgangsmåder til behandling eller forebyggelse af migrænehovedpine
DK3349758T3 (da) Fremgangsmåder til behandling af arenaviridae-virusinfektioner
IL254769B (en) Nitrobenzyl derivatives of anti-cancer agents
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
EP3359661A4 (en) MULTIPLEXED GEMONEDITATION
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3262415T3 (da) Fremgangsmåde til screening af forbindelser til behandling eller forebyggelse af en virusinfektion eller en virusrelateret tilstand
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3524255T3 (da) Sammensætning til behandling af acne
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3324867T3 (da) Indretning til akut behandling af hjertestop
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3459543T3 (da) Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi
DK3307299T3 (da) Kombinationssammensætninger til behandling af lidelser krævende fjernelse eller ødelæggelse af uønskede celleformeringer
DK3294283T3 (da) Sacubitril-valsartan-doseringsregime til behandling af hjerteinsufficiens
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3233071T3 (da) Fremgangsmåde til behandling eller forebyggelse af Ras-medierede sygdomme
DK3220952T3 (da) Fremgangsmåde til behandling eller forebyggelse af slagtilfælde
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3331610T3 (da) Midler til anvendelse til behandling af gliom